- $46.31m
- $21.31m
- $123.10m
Brief: Dominari Holdings Provides Update On Share Repurchase Program
Brief: Dominari Holdings Provides Update On Share Repurchase Program
Brief: Dominari Holdings Provides Update On Share Repurchase Program
Brief: Dominari Holdings Provides Update On Share Repurchase Program
Brief: Dominari Holdings Provides Update On Share Repurchase Program
Brief: Dominari Holdings Provides Update On Share Repurchase Program
Brief: Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes
Aikido Pharma Inc reports results for the quarter ended in September - Earnings Summary
Aikido Pharma Inc expected to post a loss of 77 cents a share - Earnings Preview
Brief: Aikido's share Repurchase Program Continues
Brief: Aikido Pharma Provides Update On Share Repurchase Program
Brief: Dominari Financial Inc Executes Definitive Agreement To Buy Broker-Dealer
Brief: Aikido Pharma Reviewed Proposal From Shalom Auerbach And Determined It Was Not Interested In Pursuing Offer
Aikido Pharma Inc expected to post a loss of 68 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Twitter, Nikola, Tesla, Xeris Biopharma
AIkido Pharma rises on $42.02 mln buyout offer from Shalom Auerbach
Brief: Aikido Pharma Confirms Receipt Of Unsolicited Offer
Advisory: Alert on buyout proposal for AIkido Pharma withdrawn
Brief: Investor Makes Proposal To Acquire Aikido Pharma For $8 Per Share In Cash